GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bajaj Healthcare Ltd (NSE:BAJAJHCARE) » Definitions » Gross Margin %

Bajaj Healthcare (NSE:BAJAJHCARE) Gross Margin % : 50.39% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bajaj Healthcare Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Bajaj Healthcare's Gross Profit for the three months ended in Dec. 2024 was ₹619 Mil. Bajaj Healthcare's Revenue for the three months ended in Dec. 2024 was ₹1,228 Mil. Therefore, Bajaj Healthcare's Gross Margin % for the quarter that ended in Dec. 2024 was 50.39%.


The historical rank and industry rank for Bajaj Healthcare's Gross Margin % or its related term are showing as below:

NSE:BAJAJHCARE' s Gross Margin % Range Over the Past 10 Years
Min: 5.67   Med: 26.23   Max: 46.26
Current: 46.26


During the past 13 years, the highest Gross Margin % of Bajaj Healthcare was 46.26%. The lowest was 5.67%. And the median was 26.23%.

NSE:BAJAJHCARE's Gross Margin % is ranked worse than
52.61% of 958 companies
in the Drug Manufacturers industry
Industry Median: 47.5 vs NSE:BAJAJHCARE: 46.26

Bajaj Healthcare had a gross margin of 50.39% for the quarter that ended in Dec. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Bajaj Healthcare was 13.50% per year.


Bajaj Healthcare Gross Margin % Historical Data

The historical data trend for Bajaj Healthcare's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bajaj Healthcare Gross Margin % Chart

Bajaj Healthcare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.26 29.41 27.04 40.09 45.26

Bajaj Healthcare Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.76 34.24 50.41 50.42 50.39

Competitive Comparison of Bajaj Healthcare's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Bajaj Healthcare's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bajaj Healthcare's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bajaj Healthcare's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Bajaj Healthcare's Gross Margin % falls into.


;
;

Bajaj Healthcare Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Bajaj Healthcare's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=2142.9 / 4734.179
=(Revenue - Cost of Goods Sold) / Revenue
=(4734.179 - 2591.272) / 4734.179
=45.26 %

Bajaj Healthcare's Gross Margin for the quarter that ended in Dec. 2024 is calculated as


Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=618.8 / 1227.94
=(Revenue - Cost of Goods Sold) / Revenue
=(1227.94 - 609.147) / 1227.94
=50.39 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Bajaj Healthcare  (NSE:BAJAJHCARE) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Bajaj Healthcare had a gross margin of 50.39% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Bajaj Healthcare Gross Margin % Related Terms

Thank you for viewing the detailed overview of Bajaj Healthcare's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bajaj Healthcare Business Description

Traded in Other Exchanges
Address
Road No. 23, Wagle Industrial Estate, 602-606, Bhoomi Velocity Infotech Park, Plot No. B-39, B-39A, B-39A/1, Thane (West), Thane, MH, IND, 400 604
Bajaj Healthcare Ltd is an India-based pharmaceutical company that manufactures Active Pharmaceutical Ingredients (APIs), Intermediates, Finished Dosage Forms, and Nutraceuticals. Its products include Intermediates, API, Formulation, and Impurities. The company derives a majority of its revenue from India.

Bajaj Healthcare Headlines

No Headlines